Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Botulinum toxin type B for cervical dystonia

Esta versión no es la más reciente

ver la versión actual 13 mayo 2016

Información

DOI:
https://doi.org/10.1002/14651858.CD004315.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2004see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos del movimiento

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • João Costa

    Correspondencia a: Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

    [email protected]

  • Cláudia C Espírito‐Santo

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Ana A Borges

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Joaquim Ferreira

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Miguel M Coelho

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Peter Moore

    The Walton Centre for Neurology and Neurosurgery, NHS Trust, Liverpool, UK

  • Cristina Sampaio

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

Contributions of authors

Protocol ‐ Costa J, Ferreira JJ, Sampaio C
Literature search ‐ Costa J, Borges A, Espírito‐Santo C
Literature selection ‐ Costa J, Borges A, Espírito‐Santo C
Papers quality assessment ‐ Costa J, Miguel C
Data collection from papers ‐ Costa J, Miguel C
Interpretation of data ‐ Costa J, Ferreira JJ, Moore P, Sampaio C
Review writing ‐ Costa J, Ferreira JJ, Moore, Sampaio C

Sources of support

Internal sources

  • Cochrane Movement Disorders Group, Portugal.

  • The Walton Centre for Neurology and Neurosurgery, UK.

External sources

  • No sources of support supplied

Declarations of interest

disponible en

Costa J, Ferreira JJ, Sampaio C, and Miguel C had been investigators in clinical trials sponsored by Elan, Allergan, and Ipsen. Ferreira JJ and Sampaio C were speakers in symposia promoted by Elan, Allergan, and Ipsen.
Moore P has received fees from various companies marketing botulinum toxin for speaking at meetings and for advice. His unit has received funds for research.

Version history

Published

Title

Stage

Authors

Version

2016 May 13

Botulinum toxin type B for cervical dystonia

Review

Raquel E Marques, Gonçalo S Duarte, Filipe B Rodrigues, Mafalda Castelão, Joaquim Ferreira, Cristina Sampaio, A Peter Moore, João Costa

https://doi.org/10.1002/14651858.CD004315.pub3

2004 Oct 18

Botulinum toxin type B for cervical dystonia

Review

João Costa, Cláudia C Espírito‐Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore, Cristina Sampaio

https://doi.org/10.1002/14651858.CD004315.pub2

2003 Jul 21

Botulinum toxin type B for cervical dystonia

Protocol

João Costa, Cláudia C Espírito‐Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore, Cristina C Sampaio

https://doi.org/10.1002/14651858.CD004315

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.